Cancer Institute A national cancer institute
designated cancer center

Studying Cancer Biology & Treatment Efficacy

Bioluminescence

Harnessing the glow-in-the-dark chemistry of fireflies, Christopher Contag, PhD, has developed a new technique for studying gene activation and cell movement as they occur in living mammals.

More

Program researchers are developing novel imaging methods to study the underlying mechanisms of cancer biology and anti-cancer drug efficacy. A key goal of their work is to develop tools to monitor cell trafficking, the behavior of cancer stem cells and the complex interaction between the immune system and cancer.

This work is carried out in collaboration with researchers from Molecular Profiling, Cancer Immunology, Hematopoietic Cell Transplantation, Lymphoma & Hodgkin's Disease, Cancer Stem Cell Biology, Radiation Biology and Cancer Biology.

Visit the Molecular Imaging Program at Stanford (MIPS) website for more information about research on cancer biology and treatment efficacy (http://mips.stanford.edu).

Scientific Goals

Program Researchers

Francis Blankenberg, MD

Helen Blau, PhD

Matthew Bogyo, PhD

Kim Butts, PhD

Christopher Contag, PhD

Gary Glover, PhD

I. Ross McDougall, MD, PhD

Michael Moseley, PhD

Norbert Pelc, ScD

F. Graham Sommer, MD

Daniel Spielman, PhD

 

 

 

Stanford Medicine Resources:

Footer Links: